Home | Cancers | Lung Cancer

Lung Cancer

Experts convene at CSHL to scrutinize, assess low-dose CT screening for lung cancer

Cold Spring Harbor, NY – At the first annual Lung Cancer Early Detection and Prevention Workshop held at Cold Spring Harbor Laboratory ...

MD Anderson study first to compare treatments, survival benefits for early-stage lung cancer

Removal of the entire lobe of lung may offer patients with early-stage lung cancer better overall survival when compared with a partial ...

Researchers reveal lung cancer can stay hidden for over 20 years

Cancer Research UK scientists have discovered that lung cancers can lie dormant for over 20 years before suddenly turning into an aggressive form of the disease, according to a study published in Science (link is external)* today (Thursday). ... Full story

Researchers identify ‘Achilles heel’ in metabolic pathway that could lead to new lung cancer treatments

DALLAS – Researchers at UT Southwestern Medical Center have found an “Achilles heel” in a metabolic pathway crucial to stopping the growth of lung cancer cells. ... Full story

Crizotinib treatment effective against ROS1-positive lung cancer

Treatment led to significant tumor shrinkage in 72 percent of treated patients ... Full story

Many patients excluded from lung cancer clinical trials due to prior cancer

DALLAS – Lung cancer clinical trials exclude a substantial proportion of patients due to a history of prior cancer, as shown in an analysis by cancer researchers at UT Southwestern Medical Center. ... Full story

Cannabis smoking may increase risk of lung cancer

University of Otago researchers have contributed to evidence that cannabis smoking may increase the risk of lung cancer in heavy users. ... Full story

For some lung cancer patients, surgery may yield better long-term results

By Vicky Agnew - Patients with early stage non-small cell lung cancer (NSCLC) who are otherwise healthy fare better over time if they undergo conventional surgery versus less-invasive radiosurgery to remove their cancer, according to a Yale study. ... Full story

Identification of Novel Mutations Causing Lung Cancer Resistance Leads to New Treatment Strategies

PHILADELPHIA — Two mutations that cause lung cancer resistance to the investigational ALK inhibitor alectinib were identified, and this information may help design new treatment regimens for patients with ALK-positive lung cancer, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. ... Full story

Patients with non-small cell lung cancer (NSCLC) who have never smoked or who have quit smoking have lower risk of developing secondary primary lung cancers than current smokers

Non-small cell lung cancer (NSCLC) survivors who never smoked or who are former smokers at the time of diagnosis have a lower risk of developing secondary primary lung cancers (SPLC) compared to those who are current smokers, suggesting that increased tobacco exposure is associated with a higher risk of SPLC, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting. ... Full story

1 2 3 4 5 6 7 8 9 10 next total: 96 | displaying: 1 - 10